Kevin Pfleger

Professor

  • The University of Western Australia (M519), 35 Stirling Highway,

    6009 Perth

    Australia

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Kevin Pfleger is Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect WA Life Sciences Innovation Hub, as well as Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research (Harry Perkins Institute of Medical Research). He is also Chief Scientific Advisor of Dimerix Limited, an ASX-listed spin-out company from UWA. Prof Pfleger was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively, and relocated to Western Australia in October 2002. He was a National Health and Medical Research Council (NHMRC) Peter Doherty Research Fellow from 2005 to 2008, an Australian Research Council (ARC) Future Fellow from 2011 to 2014, and NHMRC RD Wright Fellow (Level 2) from 2015 to 2018.

Roles and responsibilities

Director, Biomedical Innovation

Head of Molecular Endocrinology and Pharmacology

Teaching Molecular Pharmacology of GPCRs and Molecular Neuroendocrinology

Chair of Accelerating Australia Executive Committee

Board Member of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

Member of the International Advisory Group of the British Pharmacological Society

Member of the WA Branch Committee of AusBiotech

Commercialisation Representative on the WAHTN Management Committee

Education/Academic qualification

University of Cambridge

University of Edinburgh

External positions

Chief Scientific Advisor

Research expertise keywords

  • Assay technology
  • Endocrinology—receptors
  • Molecular pharmacology
  • Protein interactions
  • Bioluminescence resonance energy transfer (BRET)
  • G protein-coupled receptors (GPCR)
  • Dimerisation
  • Heteromerisation
  • Arrestin
If you made any changes in Pure these will be visible here soon.